Germinal choice technology and the human future.
This paper examines the likely impacts of emerging technologies that will give prospective parents the potential to directly influence the genetics of their offspring. My primary focus is on advanced prenatal genetic diagnosis (PGD) for both disease and non-disease traits, since this is likely to emerge before such possibilities as direct germline engineering. I place these technologies within the larger context of today's revolution in the life sciences and consider the progress likely to occur in this realm in the next few generations. I take a common sense look at the types of screening choices people are likely to make once these possibilities become possible, their broad consequences for human society, and the advantages and disadvantages of plausible regulatory paths in this realm. I also reflect upon today's debate about cloning and other such issues in the life sciences, looking at the driving forces behind these discussions and the tensions likely to develop in the next few decades.
Stock
Gregory
G
UCLA School of Public Health, Los Angeles, CA, USA. gstock@ucla.edu
D019976:Cloning, Organism; D004992:Ethics, Medical; D005053:Eugenics; D024861:Genetic Enhancement / Q000941:ethics* / Q000379:methods; D006801:Humans; D019836:Preimplantation Diagnosis / Q000941:ethics* / Q000639:trends; D012922:Social Change